1045 / 1068
NCT02526953 Russian trial (S Gordeev)
Efficacy Study of Chemoradiotherapy With or
Without Paclitaxel in Squamous-cell Anal
Carcinoma Patients
SCCA
Stage I-IIIB
314 patients
capecitabine 825
mg/m2 bid on
treatment days and
mitomycin C 12 g/m2
on day 1
paclitaxel 45 mg/m2
on days
3,10,17,24,31
Primary Endpoint 3 year DFS
capecitabine 825 mg/m2 bid on
treatment days and mitomycin
C 12 g/m2 on day 1.